z-logo
open-access-imgOpen Access
Iron status in patients with chronic heart failure
Author(s) -
Ewa A. Jankowska,
Jolanta Małyszko,
Hossein Ardehali,
E. Koc-Zorawska,
W. Banasiak,
Stephan von Haehling,
Iain C. Macdougall,
Günter Weiß,
John J.V. McMurray,
S. D. Anker,
M Gheorghiade,
Piotr Ponikowski
Publication year - 2012
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1093/eurheartj/ehs377
Subject(s) - medicine , hepcidin , iron status , heart failure , iron deficiency , disease , iron homeostasis , cardiology , inflammation , metabolism , anemia
The changes in iron status occurring during the course of heart failure (HF) and the underlying pathomechanisms are largely unknown. Hepcidin, the major regulatory protein for iron metabolism, may play a causative role. We investigated iron status in a broad spectrum of patients with systolic HF in order to determine the changes in iron status in parallel with disease progression, and to associate iron status with long-term prognosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom